Freed vs ResMed
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI medical scribe used by 20,000+ clinicians at $99/mo. $20M+ ARR. 32M+ patient visits transcribed. $30M Series A led by Sequoia Capital. Founded 2022, SF. Private.
About
Freed is an AI medical scribe founded in 2022 by CEO Erez Druk, headquartered in San Francisco. The platform listens to patient-clinician encounters and automatically generates structured clinical notes including SOAP notes, referral letters, patient instructions, and ICD-10/CPT billing codes. Priced at $99/month per clinician vs $25-50/hour for human scribes.
ResMed (RMD) reported ~$4.7B revenue in FY2024. Global leader in cloud-connected devices for sleep apnea, COPD, and out-of-hospital care, with 10M+ connected devices. HQ: San Diego.
About
ResMed Inc. is the global leader in cloud-connected medical devices and software for diagnosing and treating sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions in out-of-hospital settings. Founded in Sydney, Australia in 1989, the company designs and manufactures CPAP (continuous positive airway pressure) machines, masks, ventilators, and related accessories used by patients with obstructive sleep apnea — a condition affecting approximately 1 billion people globally that is chronically under-diagnosed and under-treated.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.